764 related articles for article (PubMed ID: 30274685)
21. miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma.
Jiang C; Long J; Liu B; Xu M; Wang W; Xie X; Wang X; Kuang M
J Exp Clin Cancer Res; 2017 Jul; 36(1):99. PubMed ID: 28750679
[TBL] [Abstract][Full Text] [Related]
22. miR-26a promoted by interferon-alpha inhibits hepatocellular carcinoma proliferation and migration by blocking EZH2.
Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
Genet Test Mol Biomarkers; 2015 Jan; 19(1):30-6. PubMed ID: 25494962
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
[TBL] [Abstract][Full Text] [Related]
25. HOXA11-AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR-124 expression by binding to EZH2.
Zhang WL; Zhao YN; Shi ZZ; Gu GY; Cong D; Wei C; Bai YS
Hum Cell; 2019 Oct; 32(4):504-514. PubMed ID: 31493246
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-26a is a key regulon that inhibits progression and metastasis of c-Myc/EZH2 double high advanced hepatocellular carcinoma.
Zhang X; Zhang X; Wang T; Wang L; Tan Z; Wei W; Yan B; Zhao J; Wu K; Yang A; Zhang R; Jia L
Cancer Lett; 2018 Jul; 426():98-108. PubMed ID: 29653269
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA‑137 has a suppressive role in liver cancer via targeting EZH2.
Cui S; Sun Y; Liu Y; Liu C; Wang J; Hao G; Sun Q
Mol Med Rep; 2017 Dec; 16(6):9494-9502. PubMed ID: 29152663
[TBL] [Abstract][Full Text] [Related]
28. miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway.
Wang J; Lu L; Luo Z; Li W; Lu Y; Tang Q; Pu J
Biomed Pharmacother; 2019 Dec; 120():109551. PubMed ID: 31648164
[TBL] [Abstract][Full Text] [Related]
29. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
[TBL] [Abstract][Full Text] [Related]
30. miR-515-5p suppresses HCC migration and invasion via targeting IL6/JAK/STAT3 pathway.
Ni JS; Zheng H; Ou YL; Tao YP; Wang ZG; Song LH; Yan HL; Zhou WP
Surg Oncol; 2020 Sep; 34():113-120. PubMed ID: 32891315
[TBL] [Abstract][Full Text] [Related]
31. Extract of
Huang X; Chen Y; Zhang X; Li F; Ye H
Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841
[No Abstract] [Full Text] [Related]
32. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.
Dang S; Zhou J; Wang Z; Wang K; Dai S; He S
Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358
[TBL] [Abstract][Full Text] [Related]
33. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
Au SL; Wong CC; Lee JM; Fan DN; Tsang FH; Ng IO; Wong CM
Hepatology; 2012 Aug; 56(2):622-31. PubMed ID: 22370893
[TBL] [Abstract][Full Text] [Related]
34. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
[TBL] [Abstract][Full Text] [Related]
35. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1.
Yuan J; Ji H; Xiao F; Lin Z; Zhao X; Wang Z; Zhao J; Lu J
Biochem Biophys Res Commun; 2017 Jan; 483(1):578-584. PubMed ID: 27998770
[TBL] [Abstract][Full Text] [Related]
37. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis.
Ma J; Weng L; Wang Z; Jia Y; Liu B; Wu S; Cao Y; Sun X; Yin X; Shang M; Mao A
Exp Cell Res; 2018 May; 366(2):103-113. PubMed ID: 29530475
[TBL] [Abstract][Full Text] [Related]
38. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
Su Z; Ye X; Shang L
Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of LncRNA ANRIL Potential in Hepatic Cancer Progression.
Ji Y; Sun H; Liang H; Wang Y; Lu M; Guo Z; Lv Z; Ren W
J Environ Pathol Toxicol Oncol; 2019; 38(2):119-131. PubMed ID: 31679275
[TBL] [Abstract][Full Text] [Related]
40. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
Huang X; Gao Y; Qin J; Lu S
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
